IOVA and REPL Related Headlines

Go Back

Apr 10, 2026 01:20PM Jefferies on Iovanace Biotherapeutics (IOVA): 'we think the pot'l risk of competition was accounted for in Street models'

IOVA and REPL Related Press Releases

Go Back

IOVA and REPL Related SEC Filings

Go Back